Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2020

May 19, 2020

30870_dirs_2020-05-18_601838df-c7c8-4028-beac-9cf63eca9a6c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-05-18

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-18 Common Stock S 811 $22.1 Disposed 303633 Direct
2020-05-18 Common Stock M 4189 $6.3 Acquired 307822 Direct
2020-05-18 Common Stock S 4189 $22.1555 Disposed 303633 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-18 Incentive Stock Option (right to buy) $6.3 M 4189 Disposed 2022-03-05 Common Stock (4189) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The 811 shares disposed of is comprised entirely of common stock purchased on 10/31/2018 pursuant to the issuer's 2015 Employee Stock Purchase Plan (ESPP).

F2: Includes 8,035 shares of common stock purchased pursuant to the ESPP.

F3: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F4: Shares held by The Brittany Blum 2003 Irrevocable Trust.